STURARO, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 349
AS - Asia 195
EU - Europa 193
SA - Sud America 8
AF - Africa 6
OC - Oceania 4
Totale 755
Nazione #
US - Stati Uniti d'America 343
IT - Italia 124
SG - Singapore 73
CN - Cina 34
IN - India 21
DE - Germania 20
ID - Indonesia 20
JP - Giappone 19
PK - Pakistan 14
GB - Regno Unito 11
FI - Finlandia 6
CA - Canada 5
KR - Corea 5
LT - Lituania 5
NL - Olanda 5
SE - Svezia 5
IR - Iran 4
PL - Polonia 4
PT - Portogallo 4
AU - Australia 3
BR - Brasile 3
CZ - Repubblica Ceca 3
EG - Egitto 3
PE - Perù 3
BE - Belgio 2
NG - Nigeria 2
RU - Federazione Russa 2
SY - Repubblica araba siriana 2
VE - Venezuela 2
CH - Svizzera 1
FR - Francia 1
GH - Ghana 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TR - Turchia 1
TW - Taiwan 1
Totale 755
Città #
Singapore 63
Ferrara 56
Santa Clara 56
Fairfield 38
Ashburn 30
Shanghai 21
Jakarta 20
Woodbridge 20
Chandler 18
Milan 17
New York 16
Princeton 11
Cambridge 10
Padova 10
Yokohama 10
Houston 8
Seattle 8
Wilmington 8
Lahore 7
London 7
Reston 7
Hamburg 6
Los Angeles 6
San Diego 6
Ann Arbor 5
Cagliari 5
Helsinki 5
Tokyo 5
Amsterdam 4
Bologna 4
Dearborn 4
Jena 4
New Delhi 4
Warsaw 4
Addison 3
Adelaide 3
Brno 3
Delhi 3
Ferrara di Monte Baldo 3
Frankfurt am Main 3
Grassano 3
Lima 3
São Paulo 3
Toronto 3
Vilnius 3
Acerra 2
Bengaluru 2
Boston 2
Brussels 2
Catania 2
Chicago 2
Falkenstein 2
Falls Church 2
Faro 2
Florence 2
Geumjeong-gu 2
Hwaseong-si 2
Lagos 2
Lisbon 2
Mumbai 2
Noida 2
Prescot 2
Pune 2
Redmond 2
Seregno 2
Accra 1
Allentown 1
Bilbeis 1
Boardman 1
Bremen 1
Brighton 1
Cairo 1
Chennai 1
Dresden 1
Fuchu 1
Hyderabad 1
Islamabad 1
Jinan 1
Lappeenranta 1
Maynard 1
Mexico City 1
Montague 1
Munich 1
Napoli 1
Ningbo 1
Olongapo City 1
Ottawa 1
Paris 1
Pickering 1
Redwood City 1
San Mateo 1
Sanming 1
Santa Maria di Sala 1
Secunderabad 1
Seoul 1
Southwark 1
Taipei 1
Tehran 1
Vadodara 1
Zurich 1
Totale 611
Nome #
New target for the development of antimigraine drugs: in vitro and in vivo study 157
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 102
Plant-derived peptides rubiscolin-6, soymorphin-6 and their c-terminal amide derivatives: Pharmacokinetic properties and biological activity 71
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 58
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes 52
Novel Mixed NOP/Opioid Receptor Peptide Agonists 49
In vitro and in vivo pharmaco-toxicological characterization of 1-cyclohexyl-x-methoxybenzene derivatives in mice: comparison with tramadol and PCP 45
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 41
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 41
Synthesis of 2,6-Dimethyltyrosine-Like Amino Acids through Pinacolinamide-Enabled C-H Dimethylation of 4-Dibenzylamino Phenylalanine 40
(L)-Monomethyl Tyrosine (Mmt): New Synthetic Strategy via Bulky ‘Forced-Traceless’ Regioselective Pd-Catalyzed C(sp2)–H Activation 35
Pharmacological characterization of naloxegol: In vitro and in vivo studies 33
Preclinical effects of cannabidiol in an experimental model of migraine 26
Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors 22
The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus 21
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 7
Totale 800
Categoria #
all - tutte 6.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 0 9 8 4 4 3 2 0
2020/2021100 3 0 8 0 29 14 2 12 3 11 3 15
2021/202290 7 0 6 12 6 6 0 8 10 5 7 23
2022/202379 9 10 4 4 3 7 14 10 4 6 7 1
2023/2024203 16 14 5 6 14 32 9 15 3 24 21 44
2024/2025294 22 35 65 48 63 61 0 0 0 0 0 0
Totale 800